Editorial Coverage

2011

• Luca Mantovani, President, DSM Pharma Chemicals, interviewed by Corrine Lawrence, Editor, Pharma Magazine. View video
• Dr. Fintan Walton interviews Xander Wessels, President and CEO of DSM Pharmaceutical Products on PharmaTV about trends in outsourcing. View video.
• Innovation in Sourcing, Industry experts share perspectives on value creation in sourcing, procurement, and external development and manufacturing.  Paul Sidhu, Vice President of Marketing and Strategy at DSM Pharmaceutical Products in Pharmaceutical Technology Sourcing & Management. By Patricia Van Arnum, 02 June 2011
• Sustainability and Pharma, an interview with DSM's Alexander Wessels, with Paul Thomas, Pharmaceutical Manufacturing.
• The Big Business of Boosting Performance, Dutch-based DSM N.V. is seeking innovative ways to partner through bolstering manufacturing, by William Looney, Pharmaceutical Executive, April 2011
• EBA Technology: Enabling the Direct Capture of Pharma Proteins - Innovations in Pharmaceutical Technology, March 2011 Learn more www.iptonline.com
• CMOs Seek "the" Competitive Edge: Established Practices Like Lyophilization and Six Sigma Are Finding Novel Uses in Biotech - Genetic Engineering & Biotechnology News March 2011
• Exploring Custom Synthesis - Contract manufacturers strengthen their toolboxes and partnerships as they navigate the changing drug-development model - Pharmaceutical Technology, January 2011
• DSM Secures Contract to Develop Water-Decontaminating Microbes - Chemical Week, 14 January 2011
• DSM further expands enzyme portfolio with Codexis accord - Outsourcing-Pharma, 13 January 2011

2010

• DSM expands process R&D offering in deal with c-Lecta - Outsourcing-Pharma, 16 December 2010
• DSM Finalizes Transformation to Life Sciences and Materials Sciences Company - Bio/Pharmaceutical Outsourcing Report , PharmSource, December 2010 - www.pharmasource.com
• European Outsourcing Awards 2010 - Pharma, November 2010
• Green Chemistry: Lighting Up New Pharma Pathways Chemical Week, March 15, 2010
• Informex exhibitors focus on green chemistry - Profiles in Sustainability, February 2010
• Chirals: The Real Deal. Is Obtaining A Chiral Molecule A Big Problem?   CHEManager Europe, January 2010

Webinars & Presentations

Reducing Downstream Harvest Steps for Improved Bioprocess Economics
Engineering & Biotechnology News Webinar, June 2011. View here

cGMP Compliance and Pharma Whistleblowing Cases
Thursday 5 May 2011, Pharmaceutical manufacturing. Register here

Diversity for Catalysts Assuring Speedy & Versatile Solutions for Scale-Up Success
March 3, 2011, 16.00 CET Register http://doiop.com/DSMwebinar

Use of Human Cells for Manufacturing Human Therapeutics
Genetic Engineering & Biotechnology News. View on Demand http://www.genengnews.com/humanexpression/

Moving to the Next Level of Technology
BioProcess International’s Online Educational Series. View On Demand http://www.bpiseminars.com/webcast/moving-to-the-next-level-of-technology.html

Sustainable Production of Pharmaceutical Intermediates and API’s
Outsourcing-Pharma. View On Demand
Sustainable Production of API`s (webinar file)

The Future for Cost-Effective, Environmentally Friendly Large-Scale API Production Outsourcing-Pharma.
View On Demand
Micro Reactor Technology (webinar file)

DSM Videos

• Daniel Hayden, Senior Vice President & General Manager, Genzyme Pharmaceuticals, talks about Genzyme-DSM partnership
• David Linn, Sr. Director, Marketing, talks about DSM at BIO 2010
• Hank Nowak, Director, Business Development talks about DSM solid dosage forms
• Karim Abdelkader, Director, New Business Development talks about DSM steriles at BIO 2010
• PharmaTelevision Special Report on DSM Pharmaceutical Products
• Paul Sidhu, Vice President, Marketing & Strategy, talks about the revolution in biomanufacturing
• Rolf Douwenga, Vice President R&D, talks about XD® Technology
• Fritjof Linz, Senior Director, Business Development & Marketing, talks about DSM Biologics technology and RHOBUST®
• Spencer Reynolds, Director, New Business Development, talks about RHOBUST®
• David Hughes, CEO of BioPharmaceuticals Australia
• Dr. Anna Lavelle, CEO of AusBiotech Ltd
• Queensland Premier, Hon. Anna Bligh, and Karen King, President DSM Biologics, discuss partnership for new drug manufacturing facility in Brisbane
• Australian Government announces plans to build biopharmaceutical manufacturing facility in Brisbane
• Laura Parks, Senior Vice President, Marketing & Sales, DSM Pharmaceuticals, Inc. at the World Vaccine Congress
• Karen King, President, DSM Biologics on DCAT TV

More Videos    

Announcements

• DSM Recognizes Employee Achievement A wide range of teams across the organization considered for Innovation & Sustainability; Operational Excellence; Safety, Health & Environment; and Winning Customer Business.
• Alexander R. Wessels new President and Chief Executive Officer of DSM Pharmaceutical Products
• DSM Receives European Outsourcing Awards for Carbon Footprint Reducing Technology 
• DSM Greenville USA Site Reaches 2 Million Hour Safety Mark!